#suitskate #JPM14 pic.twitter.com/82OVao8Qq7
— Brian Reid (@brianreid) January 14, 2014
The big JPMorgan conference in San Francisco is half over. Two-and-a-half days of entrepreneurs, investors and big promises gave Brian Reid the inspiration for a way to protect your brain from jargon overload:
By this time at #JPM14, there’s been something like 200 presentations, and certain patterns are emerging. And though so many of the buzzwords are recycled, I want to make sure the remainder of the conference is interesting. We need a drinking game. Take a sip if you hear:
“Partnership”
“Strategic partnership” [Take an extra sip]
“Innovative, strategic partnership” [Finish the glass]
“Robust”
“Unmet need”
“Unmet need in this competitive space” [Finish the bottle]
“We’re returning cash to shareholders”
“We have transformed our company for growth” (h/t to Chris Morrison)
“Skate to where the puck is going to be”
“Targeted”
“Emerging markets”
“Treatment pathways”
“The breadth of our portfolio”?
Reid is director of WCG, an integrated communications company. He specializes in life science communications, regulatory action and new media. He is a longtime Washington, D.C. journalist, so his tolerance for buzzwords must be extremely high, not to mention his expertise in translating them.
He knows how to have fun at industry events. The picture above is him taking an ice staking break Tuesday.
I need a break. Going to @UnionSquareRink in 45 minutes for a #suitskate. Who else is in? #JPM14
— Brian Reid (@brianreid) January 14, 2014
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
